← Leaderboards
Manish A Shah
Sloan-Kettering Inst Can Research
$1,510,870
Attributed
$3,198,761
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $565.7K · FY2010–22$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,531,836 · 1
FDA$666,925 · 1
By mechanism
R01$3,198,761 · 2
Top collaborators
- Olivier Elemento6 shared
- Paraskevi Giannakakou6 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Monika Laszkowska$838,080
- Mary K Baylies$14,239,165
- Xuejun Jiang$14,685,146
- Ross L Levine$31,715,816
- Song-Hai Shi$10,201,325
Others in their field
Top investigators on “Microtubules”
- Adam L Boxer · Mayo Clinic Rochester$53,170,786
- Howard J Rosen · Mayo Clinic Rochester$35,973,393
- Bradley F Boeve · Mayo Clinic Rochester$35,973,393
- Erika L Holzbaur · University Of Pennsylvania$22,516,326
- David Heimbrook · Leidos Biomedical Research, Inc.$21,781,988
- Timothy J Mitchison · Harvard University (Medical School)$19,588,395
Research focus
MicrotubulesResistanceDown-RegulationMediatingPropertyReceptor Protein-Tyrosine KinasesDiffuseDocetaxelLinkMalignant Stomach NeoplasmPharmaceutical PreparationsPlus End Of The MicrotubuleProtein IsoformsProteinsAffinityConfocal MicroscopyCellsBinding ProteinsBinding SitesImatinibChemotherapyClip-170 GeneCytoskeletonSignal Transduction
Grant awards (9)
A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore.$501,039
R01 · FY2022 · CA
A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore.$471,756
R01 · FY2021 · CA
A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore.$504,230
R01 · FY2020 · CA
A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore$61,478
R01 · FY2020 · CA
A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore.$489,103
R01 · FY2019 · CA
A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore.$504,230
R01 · FY2018 · CA
Phase 2 Irinotecan for Treatment of p53 WT Gastric Adenocarcinoma$334,719
R01 · FY2011 · FD · contact PI
Phase 2 Irinotecan for Treatment of p53 WT Gastric Adenocarcinoma$184,266
R01 · FY2010 · FD · contact PI
Phase 2 Irinotecan for Treatment of p53 WT Gastric Adenocarcinoma$147,940
R01 · FY2010 · FD · contact PI